The QualityStocks Daily Newsletter team will be off November 22nd & 23rd to enjoy time with family & friends, but we want to wish all of you a Happy Thanksgiving and we will see you again on Monday, November 26th!

The QualityStocks Daily Wednesday, November 21st, 2018

Today's Top 3 StockMarketWatch

StockMarketWatch (ABIL) +96.81%

NetworkNewsWire (ZNGY) +53.85%

Trading Concepts (QD) +36.83%

The QualityStocks Daily Stock List

Pura Naturals, Inc. (PNAT)

OTC Markets and MarketWatch reported on Pura Naturals, Inc. (PNAT), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Pura Naturals, Inc. is working to deliver a purer clean by way of its inventive BeBetter Foam®. The Company is the manufacturer of innovative foam cleaning products for the home. It has its proprietary foam technology that absorbs grease and grime like a magnet. It does so without harsh chemicals and harboring of bacteria found within traditional household cleaning products and sponges. OTCQB-listed, Pura Naturals is based in Lake Forest, California.

The Company concentrates on plant-based products made from renewable resources with no petroleum by-products. Its product portfolio includes Health & Beauty products, such as facial pads, exfoliating soap-infused body bars, soap-infused sponges, and soap-infused gentle cleansing pads for babies.

In addition, the Company has its Pura Naturals Marine. The specific design of its marine foam is to handle petroleum base contaminations. It is approved for use by the Environmental Protection Agency (EPA).

Pura Naturals’ Marine products are reusable and absorb up to 14 times their weight. Marine products include all-purpose sorbent Spill Pads, bilge sorbent Bilge Booms, Spill Bibs (fuel spill prevention), soap-infused personal cleaning bars, and soap-infused galley sponges.

The Company has its Pura Marine division. This division focuses on developing solutions utilizing AirTech Foam technologies and allied products directed towards oil spill prevention and remediation in waterways. This division is pursuing business in the trucking and oil sectors.

Pura Naturals also has its all-natural cleaning solution, Pura Pro Bio-Degreaser. This product is a strong citrus based, multi-use cleaner. The design of it is to cut through very greasy messes to leave behind only a citrus scent. The Pura Pro Bio-Degreaser earlier finished beta-testing with Pura Naturals’ partners in the marine oil transport industry.

Kitchen & Household products include sponges, soap-infused sponges, non-scratch scrubbers, and non-scratch scrubbers (soap-infused). The Company’s household cleaning product delivers a unique soap infusion. The pioneering foam absorbs grease while repelling water and inhibiting bacteria growth and odors.

This past October, Pura Naturals announced strengthening its communications and marketing strategy via the engagement of three strategic partners. JES, the award-winning singer, songwriter, DJ, producer, founder of The Rock Star Diet and soon to be cookbook author, signed a marketing agreement with Pura Naturals. JES will assist Pura Naturals in expanding its product name recognition, enhancing its consumer image, and attracting other celebrity sponsors through its product promotions with JES as a celebrity spokesperson.

Mr. Mark Barile, owner of Barile Environmental, Inc., entered into a consulting services agreement. Mr. Barile will work with Pura Naturals as its expert in supporting and strengthening its environmental product claims.

Furthermore, KCSA Strategic Communications was chosen to lead the strategic communications and investor relations programs of Pura Naturals. KCSA is a New York-based communications firm.

Pura Naturals, Inc. (PNAT), closed Wednesday's trading session at $0.00485, up 1.04%, on 2,141,224 volume with 34 trades. The average volume for the last 3 months is 16,693,210 and the stock's 52-week low/high is $0.0032/$0.34.


REGI U.S., Inc. (RGUS)

MarketWatch, Marketwired, and Stockhouse reported earlier on REGI U.S., Inc. (RGUS), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

REGI U.S., Inc., by way of its subsidiary, RadMax Technologies, Inc., engages in the design and development of axial vane-type rotary engines, known as the RadMax rotary technology, used in the design of engines, compressors, and pumps. RadMax Technologies is developing for commercialization numerous improved axial vane type rotary devices employing its Patented RadMax™ Rotary Technology. REGI U.S. is headquartered in Spokane, Washington.

The RadMax™ Rotary Technology allows for pioneering designs of lightweight and high efficiency engines, compressors, pumps, and other devices. One current prototype is The RadMax™ engine. It has only two unique moving parts, the vanes (up to 12) and the rotor, in comparison to the 40 moving parts in a basic four-cylinder piston engine.

The innovative design makes it possible to produce up to 24 continuous power impulses per one rotation, which is vibration-free and very quiet. Furthermore, the RadMax™ engine has several capabilities allowing it to operate on fuels such as gasoline, natural gas, hydrogen, propane, and diesel.

In essence, REGI U.S.’s goal is to license RadMax technology and/or participate in joint ventures (JVs) to manufacture RadMax products for specific applications. Market segments that could benefit from RadMax technology include (but are not limited to) transportation, aerospace, air conditioning and refrigeration, oil and gas production and distribution, power generation, marine, and military markets.

Last month, The Board of Directors, REGI U.S. and its wholly owned subsidiary, RadMax Technologies announced continued progress in the development of the RadMax prototype, proof-of-concept gas expander with integrated electricity generation capability. Three iterations of the expander design have developed during the past several months resulting from continual materials, sealing methods and individual component testing.

Design improvements include low friction vane and rotating seal designs that outperformed expectations. The Company stated that encouraging results from testing have led to the filing of three new provisional patents with a number of others still undergoing consideration.

REGI U.S., Inc. (RGUS), closed Wednesday's trading session at $0.0422, up 5.24%, on 1,565 volume with 2 trades. The average volume for the last 3 months is 24,450 and the stock's 52-week low/high is $0.039/$0.30.


Progressive Care, Inc. (RXMD)

OTC Markets and Investors Hangout reported on Progressive Care, Inc. (RXMD), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Progressive Care, Inc., by way of its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization. The Company is moving ahead in its work to grow the Company by expanding its facility, adding new locations, acquiring operating pharmacies, and further developing its current business lines. Progressive Care is based in North Miami Beach, Florida.

Progressive Care is a provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), and the supply of prescription medications to long term care facilities. In addition, the Company is a provider of administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management.

Progressive Care owns PharmCo LLC. PharmCo was created in 2005 as a Florida Limited Liability Corporation with the goal of becoming a premier pharmacy in the South Florida community. PharmCo has developed into a health services enterprise that focuses on the provision of prescription pharmaceuticals.

PharmCo’s compounding department specializes in formularies including non-narcotic topical pain creams, wound care creams, scar gels, and hormone replacement therapies. Furthermore, PharmCo offers EnovaRx, which are Food and Drug Administration (FDA) approved manufactured pain creams. These are readily available with a prescription.

PharmCo also prepares psoriasis creams, wellness vitamins, weight loss formulations and holistic capsules. These are 100 percent Kosher and Halal certified.

On September 1, 2016, Progressive Care opened Smart Medical Alliance, Inc. It opened Smart Medical to assist healthcare providers with navigating the complex risk management environment of their insurance network contracts. Smart Medical Alliance provides management and support services to doctors and administrators under capitated and fee-for-services insurance contracts.

This month, Progressive Care announced that it executed a Letter of Intent (LOI) to purchase a pharmacy in Palm Beach County. The Company signed an LOI on March 1, 2018 to purchase a pharmacy in Palm Beach County for $300,000. Progressive Care is starting the due diligence process with expected closing to take place in Q2 of 2018. The acquisition target is close to major highways in a 3,000 sq. ft facility. The operation has experienced staff, all applicable licenses, and commensurate PBM contracts as PharmCo, LLC, and a Parata PASS 500 unit dose packaging system.

Additionally, this month, Progressive Care announced strong sales for the month of February 2018. PharmCo, LLC filled more than 19,500 prescriptions during February, producing close to $1.45 million in Net Revenues. Prescriptions filled grew by 18 percent versus the same month the year prior.

The Company stated that Revenues remained flat year over year. Also, Progressive Care filled more than $450,000 worth of prescriptions (not included in Net Revenues) for 340B entities in February, generating fees to the pharmacy of roughly $20,000. This is almost a 200 percent increase over the same month the year prior.

Progressive Care, Inc. (RXMD), closed Wednesday's trading session at $0.06, up 3.45%, on 114,486 volume with 24 trades. The average volume for the last 3 months is 1,458,890 and the stock's 52-week low/high is $0.012/$0.266.


MGT Capital Investments, Inc. (MGTI)

InvestorsHub and OTC Markets reported on MGT Capital Investments, Inc. (MGTI), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

MGT Capital Investments, Inc. ranks as one of the largest U.S.-based Bitcoin miners. The Company’s facility in WA State produces roughly 80 Bitcoins monthly. In addition, MGT continues to focus on an expansion model to grow its crypto assets materially. MGT Capital Investments is based in Durham, North Carolina. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Additionally, MGT Capital Investments is developing a portfolio of cyber security technologies, creating advanced protection technologies for mobile and personal technology devices, and corporate networks. Industry pioneer Mr. John McAfee is the Company’s visionary leader in this corporate initiative.

MGT’s first product is named Sentinel. This is an enterprise class network intrusion detector. Sentinel watches one’s network and reacts immediately upon noticing suspicious activity. John McAfee engineered the Sentinel system.

Moreover, the Company has entered into a joint venture (JV) with Nordic IT Sourcing Association Venture Partners. This JV is to develop and market a mobile phone with extensive privacy and anti-hacking features. The tentative release date of the Privacy Phone is February 2018.

MGT Capital Investments is responsible for designing, engineering, as well as testing a state-of-the-art cell phone with privacy features that stay one step ahead of hackers and eavesdroppers. Nordic IT is responsible for sourcing strategic partners to manufacture and assemble the phone. Moreover, Nordic IT is responsible for sales and marketing.

Furthermore, MGT signed a Letter of Intent (LOI) with Bitmain Technologies Limited. This is to form a JV, which will concentrate on opportunities in the Bitcoin space in North America. The proposed JV between MGT Capital Investments and Bitmain Technologies will lead to the development of a state-of-the-art Bitcoin mining pool.

MGT has also entered into a consulting agreement with Future Tense Secure Systems Inc. Future Tense is a technology incubator with investments in other applications requiring privacy, such as file sharing and chat.

Last month, MGT Capital Investments provided an update at its Annual Meeting of Stockholders. It provided an update on its different business initiatives.

Concerning Bitcoin mining activities, Mr. Stephen Schaeffer, President of MGT's Crypto Capital Strategies division, stated in December, "We are ecstatic to report that we have entered into agreements to secure reliable and adequate electric power in Sweden, and expect to begin deployment of mining rigs there by the end of next month.  Moreover, the initial phase of this relationship will give the Company 25 MW of power, enough for over 15,000 Bitmain S-9 mining rigs."

MGT Capital Investments, Inc. (MGTI), closed Wednesday's trading session at $0.089, even for the day, on 1,185,472 volume with 129 trades. The average volume for the last 3 months is 2,181,826 and the stock's 52-week low/high is $0.052/$8.14.


DiaMedica Therapeutics, Inc. (DMA.V)

Penny Stock Hub, Zacks, OTC Markets, Barchart, Business Insider, StreetInsider, MarketWatch, Stockhouse, GuruFocus, Marketwired, The Street, and WeeklyHub reported earlier on DiaMedica Therapeutics, Inc. (DMA.V), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

DiaMedica Therapeutics, Inc. focuses on improving the lives of patients with neurological and kidney diseases associated with low KLK1 levels. It is developing unique treatments where there is significant unmet clinical need or where no current therapies are available with an emphasis on neurological and kidney diseases. A clinical stage biopharmaceutical company, DiaMedica Therapeutics formerly went by the name DiaMedica, Inc.  It changed its name to DiaMedica Therapeutics, Inc. in December 2016. DiaMedica is based in Minneapolis, Minnesota.

The Company is developing DM199. This is a recombinant (synthetic) human protein for patients suffering from neurological and kidney diseases. DM199 has undergone clinical testing that demonstrates its exceptional safety as a potential treatment for a variety of disorders. DiaMedica Therapeutics is positing DM199 for the treatment of diabetic nephropathy and post-insult treatment from acute ischemic stroke (AIS).

Currently, DiaMedica is conducting a clinical trial designed to identify a dose of DM199 that is comparable to the human urinary and porcine approved versions in Asia. The results of this study will direct dosing for Phase II and Phase III clinical trials.

DiaMedica has also identified chronic kidney disease (CKD) caused by Type 1 diabetes as the primary indication for its first kidney disease trial. It announced in February 2018 the first patient enrollment, at the Royal Melbourne Hospital, Melbourne Australia, in its Phase 2 REMEDY trial assessing the safety, tolerability and markers of therapeutic efficacy of DM199 (recombinant human KLK1) in patients suffering from acute ischemic stroke.

Ahon Pharmaceutical Co Ltd. (Ahon Pharma), a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co. Ltd, (Fosun Pharma) and DiaMedica Therapeutics have entered into a license and collaboration agreement. This agreement allows Ahon Pharma to have exclusive rights to develop and commercialize DM199 for acute ischemic stroke in mainland China, Taiwan, Hong Kong S.A.R. and Macau S.A.R. Fosun Pharma is one of China’s largest pharmaceutical firms.

With this license agreement, DiaMedica Therapeutics is entitled to receive an upfront payment of $5 million, comprising $500,000 on signing and $4.5 million upon regulatory clearance to start a clinical trial in China. In addition, DiaMedica has the potential to receive an additional $27.5 million in development and sales related milestones and high single and low double-digit royalties on net sales of DM199 in the licensed territories.  All development, regulatory, sales, marketing, and commercial activities and associated costs in the licensed territories will be the sole responsibility of Ahon Pharma.

DiaMedica Therapeutics, Inc. (DMA.V), closed Wednesday's trading session at $5.60, down 1.93%, on 5,010 volume with 19 trades. The average volume for the last 3 months is 7,600 and the stock's 52-week low/high is $4.19/$18.00.


RenovaCare, Inc. (RCAR)

Zacks, Insider Financial, and MarketWatch reported on RenovaCare, Inc. (RCAR), and today we report on the Company, here at the QualityStocks Daily Newsletter.

RenovaCare, Inc. is developing first-of-their-kind autologous (self-donated) stem cell therapies for the regeneration of human organs. The Company’s initial product under development targets the body’s largest organ, the skin. RenovaCare is the developer of the patented CellMist™ and SkinGun™ technologies. These are for isolating and spraying a patient’s own stem cells onto burns and wounds for quick self-healing. RenovaCare is headquartered in New York, New York.

RenovaCare’s flagship technology, the CellMist™ System, employs its patented SkinGun™ to spray a liquid suspension of a patient’s stem cells – the CellMist™ Solution – onto wounds. The Company is developing its CellMist™ System as a promising new option for patients suffering from burns, chronic and acute wounds, and scars.

The CellMist™ System targets patients worldwide who suffer burns, chronic and acute wounds, acne scarring, and skin defects and diseases such as vitiligo. Based on preliminary case studies, CellMist™ System patients can be treated within 90 minutes of entering an emergency room. A patient’s stem cells are isolated, processed, and sprayed onto wound sites for fast healing.

In investigative clinical use in the U.S., SkinGun™ treatments have shown the potential to naturally and quickly heal burns and other serious wounds.

Skin stems cells sprayed with RenovaCare`s patented SkinGun™ device maintain 97.3 percent cell viability. There is no impairment to cell growth or metabolic activity when evaluated in vitro. In 2017, RenovaCare miniaturized the SkinGun™ from the size of a microwave to a device that fits comfortably in one hand.

The Company has a partnership to validate the science behind its unique technology for treatments of wounds, burns, and other skin defects. Its research partner is Berlin-Brandenburg Center for Regenerative Therapies (BCRT).

The next major milestone for RenovaCare will be its initial Food and Drug Administration (FDA) filing. The FDA filing will advance the Company’s innovative technology towards market. Its initial FDA filing will be to demonstrate the safety and efficacy of its approach for treating wounds utilizing a patient’s own skin cells.

As of February 26, 2018, more than 70 patients in the United States and Europe have been treated with the technology underlying the RenovaCare cell spray system.

In March, RenovaCare announced the appointment of Mr. Harmel S. Rayat, long-time majority stockholder, as Chairman of its Board of Directors. Mr. Rayat has invested almost $6 million in RenovaCare and its stem cell spray technologies.

Mr. Rayat is an established entrepreneur-investor. He is best known for his portfolio of Class-A commercial properties in the United States and Canada. In his role as Chairman, he will work with the Board to support RenovaCare President and Chief Executive Officer, Mr. Thomas Bold, senior Company Management, and clinical and regulatory teams as they work to bring the Company’s cell spray therapies to market.

RenovaCare, Inc. (RCAR), closed Wednesday's trading session at $1.65, up 0.65%, on 36,650 volume with 18 trades. The average volume for the last 3 months is 24,226 and the stock's 52-week low/high is $1.18/$12.82.


K92 Mining, Inc. (KNTNF)

Hotstocked, Future Money Trends, Resource Stock Digest, TradeKing, Investors Hangout, GuruFocus, Marketwired, YCharts, Stockhouse, MarketWatch, InvestorsHub, Barchart, OTC Markets, The Prospector News, Dividend Investor, and Morningstar reported on K92 Mining, Inc. (KNTNF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

K92 Mining, Inc. engages in the exploration and development of mineral deposits in Papua New Guinea. The Company has started gold production from the Irumafimpa Gold Deposit that together with the Kora Gold Deposit is part of its Project situated in the Eastern Highlands province of Papua New Guinea. OTCQX-listed,  K92 Mining is headquartered in Vancouver, British Columbia.

Kainantu highlights include existing infrastructure. This includes underground mine development, a mill processing facility, staff housing, a licensed tailings pond, office space, paved access roads, and a reliable hydro supply through a dedicated power line. The Kainantu property encompasses a total area of approximately 410km2.

Additionally, Kainantu highlights include USD $41.3 million invested in exploration drilling and definition drilling. The current resource estimate is based on 78,935m of drilling through 767 drill holes. The Process Mill earlier successfully treated the initial batch of underground ore delivered from Irumafimpa, with concentrate now produced.

There exists a significant opportunity to expand known zones of mineralization, and for the discovery of new ore bodies. K92 Mining reached and declared commercial production, effective February 1, 2018, at its Kainantu Gold Mine in Papua New Guinea.

This month, K92 Mining announced that an updated resource estimate was completed at its Kora North deposit, based on results from underground grade control, exploration diamond drilling, as well as face sampling. The updated resource estimate consists of a Measured Resource of 154,000 tonnes @ 18.7 g/t Au, 8.9 g/t Ag and 0.5 percent Cu; an Indicated Resource of 690,000 tonnes @ 11.6 g/t Au, 14.1 g/t Ag and 0.8 percent Cu and an Inferred Resource of 1.92 million tonnes @ 10.7 g/t Au, 13.3 g/t Ag and 0.7 percent Cu.

This represents an increase of greater than 20 percent in the contained gold equivalent ozs for the Measured and Indicated Resource and almost 30 percent for the Inferred Resource. This resource estimate covers an area of roughly 400 to 500 meters along strike by 200 to 350 meters vertically, representing about 15 percent of the target area of 1,000 meters along strike by up to 1,000 meters vertically that K92 Mining plans to drill from underground over the coming 12 months.

K92 Mining, Inc. (KNTNF), closed Wednesday's trading session at $0.549, up 1.67%, on 32,633 volume with 27 trades. The average volume for the last 3 months is 77,079 and the stock's 52-week low/high is $0.3095/$0.7945.


ProtoKinetix, Inc. (PKTX)

SmallCapVoice, OTCReporter, Stock Rich, PennyStockAce, Stockpalooza, SuperBirdStocks, WallStAlerts, Willy Wizard, Pick Alerts, Penny stock Profitz, AllPennyStocks, Penny Invest, CoolPennyStocks, TopPennyStockMovers, 777 Stocks, Breaking Bulls, InsideBulls, Stock Market News Alert, HotOTC, StockEgg, and Round Up the Bulls reported previously on ProtoKinetix, Inc. (PKTX), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

ProtoKinetix, Inc. is a molecular biotechnology company headquartered in Marietta, Ohio. The Company has developed and patented a family of hyper stable, potent glycopeptides (Anti-Aging GlycoPeptide - AAGP™) that enhance engraftment and protection of transplanted cells used in regenerative medicine.

Due to the anti-inflammatory effect of AAGP™ molecules, ProtoKinetix is currently targeting the direct treatment of diseases that have a significant inflammatory component. The Company’s molecule, AAGP™, is an antifreeze glycopeptide. It imitates a naturally occurring glycoprotein found in Arctic fish.

ProtoKinetix’s AAGP™ molecule is helping to substantially improve the efficacy of Cell Transplant Treatments for diabetes. The Company has broad patent protection for its portfolio of anti-aging glycopeptides.

Its anti-aging glycopeptide, trademarked AAGP™, is a small (580.96 Daltons), stable, synthetic replica of the larger (>2,600 Daltons), less stable AFGP, which has been found to have protective properties in nature.

The small size of AAGP™ allows it to penetrate cells. It allows it to pass through cell and capillary junctions in vivo. Furthermore, its bioactivity at a range of pHs (5.3-10.3) and temperatures (-196°C to 22°C) and efficiency at concentrations (1mg/ml) is well under its toxic dose (50mg/ml). This makes it a candidate to enter the next stages of translational research.

ProtoKinetix and Proactive Immune Sciences entered into a joint research collaboration. The aim of the research is to test the effect of the patented anti-aging glycopeptide AAGP™ on the immune cell cryopreservation protocols used by Proactive Immune Sciences. Proactive Immune Sciences stores (banks) immune cells, while people are healthy. This is for them to use later in life should they contract cancer or have other immune system related diseases.

ProtoKinetix earlier provided a scientific update on immune cell banking and functions relevant to immunotherapy using AAGP™ in collaboration with Proactive Immune Sciences. In 2017, Proactive began a research program, which used an anti-aging glycopeptide (AAGP™) produced by ProtoKinetix that, among other uses, has shown the potential to benefit a variety of cells during cryopreservation.

In January 2018, ProtoKinetix announced that it entered into a research agreement with The University of British Columbia (UBC), under the direction of principal investigator Dr. Kelly McNagny, Professor, Faculty of Medicine, Department of Medical Genetics. The research agreement is to test and establish the effect of AAGP™ on monoclonal antibody production and bone marrow recovery.

The University of British Columbia’s Antibody Lab will test whether AAGP™ enhances the production of monoclonal antibodies from cell lines. Additionally, UBC will test whether AAGP™ enhances the survival/efficacy of engraftment of hematopoietic stem cells.

ProtoKinetix, Inc. (PKTX), closed Wednesday's trading session at $0.0785, up 20.77%, on 100 volume with 1 trade. The average volume for the last 3 months is 64,935 and the stock's 52-week low/high is $0.029/$0.129.


Sun Pacific Holding Corp. (SNPW)

Marketwired, Zacks, 4-Traders, MarketWatch, and Investorx reported earlier on Sun Pacific Holding Corp. (SNPW), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Sun Pacific Holding Corp., via its subsidiaries, provides solar bus stops, solar trashcans and “street kiosks” using its inventive advertising offerings, which provide state and local municipalities with cost efficient solutions. The Company’s subsidiaries include Sun Pacific Power Corp., Street Smart Outdoor Corp., Sun Pacific Security Corp., and National Mechanical Group. A green energy company, Sun Pacific is headquartered in Manalapan, New Jersey.

Sun Pacific specializes in solar and waste to energy technologies. Subsidiary Sun Pacific Power builds next generation solar panels and lighting products made primarily in the United States. Sun Pacific Power has eight worldwide manufacturing and assembly locations. These include five in the U.S.

Subsidiary Sun Pacific Security will offer customers the latest in security automation systems. This subsidiary enables one to view secure, live and recorded video of their property at any time on their computer, smartphone or tablet. Sun Pacific Security has not started operations in the security sector. It is reviewing plans to provide customers the latest in security automation systems.

Street Smart Outdoor is Sun Pacific’s street furniture outdoor advertising subsidiary. At present, it is maintaining advertising space on over 1,000 bus shelter faces, bus benches, smart solar digital shelters and solar trash bins.

Company subsidiary Sun Pacific Power provides solar powered bus shelters, solar powered LED trash bins, solar products and lighting products. The Smart Solar Bus Shelter provides LED lighting for increased visibility and security and other technological additions not previously available.

Sun Pacific is integrating blockchain technology into its renewable energy business model and strategy designed to improve grid management efficiency for solar and wind farms. It previously signed a Letter of Intent (LOI) to purchase 60 acres of land to build a solar and wind farm, where electricity generation will be optimized through a combination of both energy sources. The Company plans to take the project one step closer to the future through using blockchain technology to monitor the new grid, load balance, and increase the life of electrical equipment.

Recently, Sun Pacific announced that it completed the engineering and environmental study for its MedRecycler-RI, Inc. Medical Waste to Energy Project to be located in Johnston Rhode Island. Completion of the engineering and environmental studies that were performed over the past several months have now been completed as part of the milestones required to meet the different regulatory and financing requirements to install the 70 tons per day medical waste-to-power system. The system is a thermal processing system. It features state-of-the-art pollution controls that will accept medical waste, directly process the waste, and produce electrical energy.

Sun Pacific Holding Corp. (SNPW), closed Wednesday's trading session at $0.021, down 21.64%, on 84,513 volume with 6 trades. The average volume for the last 3 months is 112,961 and the stock's 52-week low/high is $0.019/$0.819.


Anvia Holdings Corporation (ANVV)

High Rising Stocks, Simply Wall St, Wallmine, Investors Hangout, Street Insider, Jet Life Penny Stocks, Stockopedia, Barchart, Stockhouse, Stock Orange, OTC Markets, 4-Traders, GuruFocus, Stockwatch, Penny Stock Hub, Morningstar, and TradingView reported on Anvia Holdings Corporation (ANVV), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Anvia Holdings Corporation is a global technology company headquartered in Glendale, California. Anvia is a global technology business that creates comprehensive, turnkey software and consulting solutions for small to medium-sized businesses. The Company is also the world’s complete eco-system for tradesmen in the construction industry. Its businesses serve the complete lifecycle of tradesmen or handymen in the construction industry. Anvia works to build competent tradesmen for the construction industry and make them accessible to the market.

Anvia is the first integrated platform for blue-collar workers in the construction industry to provide qualification, licensing, continuous education, placement services, entrepreneurship opportunities, and cash-back or loyalty programs in Australia and around the world. The Company has its Anvia College. This College offers quality and world-class education services and products to its aspiring tradesmen and construction workers in a blended learning environment. Anvia College provides essential qualification courses related to the construction environment.

In addition, Anvia has its Anvia Recruiters. Anvia Recruiters provides employment services to graduates of Anvia College and Anvia members worldwide. Moreover, the Company has its Anvia Market. Anvia market is an online store for tradesmen or handymen involved in the construction industry to purchase safety wear and tools.

Anvia also offers its Anvia Loyalty. This is a free loyalty program by the Company designed for existing qualified and aspiring tradesmen. Anvia Loyalty is a single platform. It connects the Company’s members to all Anvia products and services.

Anvia Holdings announced in May 2018 that it fully acquired Anvia (Australia) Pty Ltd, formerly known as Kasa Corporation (Australia) Pty Ltd. Anvia (Australia) Pty Ltd is fully-owned subsidiary of Anvia Holdings. Anvia Australia commercializes Anvia’s intellectual property (IP) assets. These assets include Anvia Learning, Anvia Market, Anvia Recruiters and Anvia Loyalty in the Australian Market.

In June 2018, Anvia (Australia) Pty Ltd announced that it acquired all of the issued and outstanding shares of Global Institute of Vocational Education Pty Ltd (Melbourne, Australia).  Global Institute of Vocational Education is a Registered Training Organization (RTO) under Australian Qualification Framework (AQF) by Australian Skills Quality Authority (ASQA).

Last month, Anvia announced that it executed an agreement to acquire all of the issued and outstanding shares of Entrepreneur Culture Inc Sdn Bhd. This is a Malaysia turnkey franchise development, registration and growth company, trading under the brand the franchise culture (The Franchise Culture). The company has been a Registered Franchise Consultant with Malaysian government agencies to assist small and medium businesses develop, register and grow their franchise system. It is among few registered franchise brokers licensed by the Malaysian government.

This month, Anvia Holdings announced it designed and implemented a decisive rebranding. The new Anvia brand projects a modern minimalistic look and feel. It has adopted a new brand essence and positioning statement. The old position statement was, “Eco-System for Construction Tradesmen.” The new position statement is, “Making Personal And Business Growth Accessible.”

Anvia Holdings Chief Executive Officer, Ali Kasa, said “The investment in the rebranding exercise was critical to articulate a simple and clear brand story. In view of recent and planned acquisitions, the company has aligned Anvia and its operating entities to put together a platform for both consumers and businesses to have access to growth tools and services.”

Anvia Holdings Corporation (ANVV), closed Wednesday's trading session at $1.00, up 25.00%, on 2,000 volume with 3 trades. The average volume for the last 3 months is 1,072 and the stock's 52-week low/high is $0.51/$1.70.


Uniroyal Global Engineered Products, Inc. (UNIR)

NetworkNewsWire, Infront Analytics, Capital Cube, Capital Network, Proactive Investors, 4-Traders, Morningstar, MarketWatch, Zacks, Stockhouse, Wallet Investor, Real Investment Advice, Marketbeat, and Zacks reported earlier on Uniroyal Global Engineered Products, Inc. (UNIR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Uniroyal Global Engineered Products, Inc., through its subsidiaries, is a leading manufacturer of vinyl coated fabrics. These fabrics are durable, stain resistant, cost-effective alternatives to leather, cloth, and other synthetic fabric coverings. OTCQB-listed, Uniroyal Global Engineered Products (UNIR) is headquartered in Sarasota, Florida.

UNIR’s main brand names include Naugahyde®, BeautyGard®, Flameblocker™, and Spirit Millennium®. Additionally, its brand names include Ambla®, Amblon®, Velbex®, Cirroflex®, Plastolene® and Vynide®.

The Company is a foremost supplier of vinyl coated fabric materials for the automotive and commercial industries. Its products in the automotive industry are used primarily in seating, door panels, head and arm rests, security shades, and also trim components. UNIR’s non-automotive applications include outdoor seating for utility and sports vehicles, and sheeting used in medical, nuclear protection, personal protection, moisture barriers, pool liners, pram and nursery, movie screen, and decorative surface applications.

UNIR announced in July of this year that its subsidiary, Uniroyal Engineered Products, LLC, achieved IATF 16949:2016 certification. This is the highest international quality standard for the automotive industry.  This certification covers UNIR’s Stoughton, Wisconsin plant, R&D lab and test facility.  Furthermore, the Company’s Stoughton facility holds the ISO 9001:2015 certification.

Earlier this month, UNIR reported its financial results for Q3 and nine months ended September 30, 2018. Q3 financial highlights include Net Sales increasing 8.1 percent on growth in all three major business segments. Operating Income was up 30.2 percent in comparison to the prior year quarter. Earnings (Loss) Per Common Share was at breakeven in comparison to a loss of $0.03 in the prior year quarter.

The Industrial and Contract segments improved mainly because of an improved United States economy that boosted sales to equipment manufacturers and the re-upholstery marketplace. The Company noted that the growth in the Automotive segment is because of “wins” in new platforms that UNIR has been positioning for some time.

The Automotive segment (64.6 percent of Net Sales) recorded increases of 6.4 percent in comparison to the prior year with the U.S. and United Kingdom (UK) operations showing improvement. The Industrial segment (including Contract; 35.4 percent of Net Sales) increased 11.3 percent in comparison to the prior year.

Uniroyal Global Engineered Products, Inc. (UNIR), closed Wednesday's trading session at $1.30, up 13.04%, on 720 volume with 5 trades. The average volume for the last 3 months is 1,127 and the stock's 52-week low/high is $1.00/$2.04.


AXIM Biotechnologies, Inc. (AXIM)

CFN Media Group, Simply Wall St, Promotion Stock Secrets, Insider Financial, Market Screener, TopPennyStockMovers, BioSpace, Daily Marijuana Observer, Wallet Investor, and SmallCapVoice reported on AXIM Biotechnologies, Inc. (AXIM), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

AXIM Biotechnologies, Inc. is a biotechnology company based in New York City. It centers on the research, development, and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products. AXIM discovers and brings to market innovative solutions by way of research and development (R&D), strategic partnerships, and acquisitions through setting the green standard in the industrial hemp industry. Medical Marijuana, Inc. (MJNA) is a major investor in AXIM. AXIM Biotechnologies’ shares trade on the OTC Markets Group’s OTCQB.

The Company’s focus is on unique, proprietary delivery mechanisms for the introduction of cannabinoids and finding solutions for conditions for which there is presently no effective treatment. AXIM Biotechnologies is advancing its patented controlled-release cannabinoid gum in studies covering a number of indications.

AXIM’s Intellectual Property (IP) portfolio currently includes two fully issued patents – one patent permitting the use of CBD (cannabidiol) in controlled-release, functional chewing gum, and another patent for chewing gum containing natural and synthetic cannabinoids for the treatment of pain, and 15 patent applications in varied stages of approval.

The Company’s flagship CanChew Plus® contains 10mg of cannabidiol (CBD) obtained from industrial hemp plants. AXIM also has its CanChew+ 50®. This product contains 50 mg of CBD. CanChew+ 50®is undergoing clinical trials in patients with IBS (Irritable Bowel Syndrome).

AXIM’s pipeline of IP protected cannabinoid-based products additionally includes MedChew Rx™. This THC/CBD cannabinoid controlled-release chewing gum is to address pain and muscle spasticity in multiple sclerosis (MS) patients. It is the world’s first patented cannabinoid controlled-release chewing gum.

AXIM Biotechnologies announced in August 2018 positive results from stability and dissolution tests performed on its primary drug candidate, MedChew Rx®, which will undergo clinical trials for the treatment of pain and spasticity in Multiple Sclerosis (MS) patients. Results showed that the primary Active Pharmaceutical Ingredients (APIs) in MedChew Rx™ remained stable throughout the test and that the availability of the APIs was greater than 90 percent.

Recently, AXIM Biotechnologies announced that the United States Patent and Trademark Office (USPTO) issued a patent (US 10,092,538 B2) on a suppository composition consisting of cannabinoids developed by AXIM. The USPTO made the determination that a patent can be granted from AXIM’s patent application, filed in October 2017. At present, the Company is contemplating continuous clinical trials at the University of Wageningen in the Netherlands for treatment of indications such as IBD and IBS with AXIM’s cannabinoid-based suppository product and CanChew® Rx CBD (cannabidiol) functional, controlled release chewing gum.

AXIM Biotechnologies, Inc. (AXIM), closed Wednesday's trading session at $1.01, down 6.48%, on 42,234 volume with 76 trades. The average volume for the last 3 months is 109,456 and the stock's 52-week low/high is $0.90/$10.29.


Organigram Holdings, Inc. (OGRMF)

Penny Stock Tweets, Daily Marijuana Observer, TradingView, Microcap Daily, The Street, Wallet Investor, Marijuana Stock, Marijuana Stocks Report, CFN Media Group, InvestorPlace, Wealth Daily, Cannabis Financial Network News and Money Morning reported previously on Organigram Holdings, Inc. (OGRMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Organigram Holdings, Inc.’s focus is on producing the highest-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada. The Company’s wholly-owned subsidiary, Organigram, Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram has developed a portfolio of brands. These include The Edison Cannabis Company, Ankr Organics, Trailblazer and Trailer Park Buds. Organigram’s head office, production facility, and Research and Development (R&D) are in Moncton, New Brunswick.

Organigram provides a varied array of genetics and product types. These cater to the individual needs of each client. The Company offers a reliable supply of premier quality, industry-leading strains to match individuals’ personal needs. The Company has collaborations with healthcare experts and academic institutions. It invests in medical education, outreach, and also research for the use of cannabinoids as a first line of treatment.  

Organigram is undergoing a production-facility expansion. The expansion will more than triple the size of its operations. The multi-million-dollar project will meet the increasing needs of its medical patient base, and prepare it for the legal, adult-recreational marijuana market.

The Company’s plans also include a production-capacity increase from about 5,200 kilograms (kg) per year to more than 25,000 kg per year. Plans additionally include the acquisition of a third building at 55 English Drive for future expansion, next to the current campus.

Organigram Holdings and Eviana Health Corporation jointly announced this past June that they entered into a non-binding term sheet. Organigram will make a significant equity investment into Eviana. The Term Sheet also contemplates Organigram entering into an offtake agreement with Eviana for up to 50 percent of the cannabidiol (CBD) production of Eviana for a period of five years. This is subject to adjustment based on Organigram’s equity interest in Eviana.

Last month, Organigram Holdings announced that it, via its wholly-owned subsidiary 10870277 Canada, Inc. (OGI), executed an investment agreement dated as of October 10, 2018 with alpha-cannabis® Pharma GmbH (ACG) wherein the Purchaser will acquire 8,333 common shares of ACG, representing a 25 percent stake in the capital of ACG, for aggregate proceeds of €1,625,000.

Mr. Greg Engel, Organigram Chief Executive Officer, said, "As we continue to build the framework of our international medical business, finding the right partners in the right markets has been a priority for our company. This relationship is a perfect example of two companies coming together towards a common goal, and we're very excited to build our business in Germany through our partners at alpha-cannabis® Pharma GmbH."

Organigram Holdings announced recently that it signed a supply agreement with the Province of British Columbia. The Company signed an agreement with the BC Liquor Distribution Branch (BCLDB), the sole, wholesale distributor of non-medical cannabis for the Province, which will operate standalone, public retail stores and provide online sales. To date, Organigram has secured cannabis distribution agreements in eight of ten provinces.

Organigram Holdings, Inc. (OGRMF), closed Wednesday's trading session at $4.0843, up 4.20%, on 240,697 volume with 608 trades. The average volume for the last 3 months is 1,151,500 and the stock's 52-week low/high is $2.42/$6.68.


NanoVibronix, Inc. (NAOV)

Zacks, InvestorsHub, and MarketWatch reported on NanoVibronix, Inc. (NAOV), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTC BB-listed, NanoVibronix, Inc. is a medical device company using its proprietary and patented low intensity surface acoustic wave technology. The Company’s pioneering technology allows for the creation of low-frequency ultrasound waves, which can be used for an array of medical applications, including the disruption of biofilms and bacteria colonization, and also providing pain relief. NanoVibronix has its headquarters in Elmsford, New York. The Company’s Research and Development (R&D) is in Nesher, Israel.

NanoVibronix’s products include PainShield®, UroShield™, NG-Shield™, and WoundShield™. These devices can undergo administration at home, without the aid of medical professionals. The PainShield® device is a wearable, battery powered electronic unit. It uses a disposable patch through which it delivers localized energy creating therapeutic effect to relieve localized pain and stimulate soft tissue healing.

The UroShield™ system is a multi-targeting solution. Its intention is to work against several factors, which are vital in preventing catheter related complications. The NG-Shield™ utilizes the Company’s proprietary acoustic technology onto the Nasogastric tube in such a way that it noticeably decreases the trauma and effective friction of the tube and blocks tube associated pain and discomfort.

The WoundShield™ system is a novel, patch-based therapeutic ultrasound device. It facilitates soft tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. The WoundShield™ may also be used to enhance oxygen and topical drugs delivery. In December 2016, NanoVibronix announced that it received clearance to sell the WoundShield™ in Canada.

This past March, NanoVibronix announced that it was granted a patent by the United States Patent and Trademark Office (USPTO) entitled, "System and Method for Surface Acoustic Wave Treatment of Skin," with a term through 2033, which does not include regulatory extensions.

The Company’s Surface Acoustic Wave (SAW) technology employs a portable patch-based therapeutic device to facilitate soft tissue regeneration by producing ultrasound surface acoustic waves on the skin to increase local capillary perfusion and tissue oxygenation. The surface acoustic waves extend beyond the skin contact area of the device. Therefore, this allows treatment of infected skin areas without painful contact between the device and the infected area.

Recently, NanoVibronix announced successful interim trial results for UroShield™. The trial was conducted at two skilled nursing facilities near Buffalo, New York, in which 22 subjects underwent evaluation.

Mr. Brian Murphy, NanoVibronix Chief Executive Officer, said, "We are very excited to report the results of this latest study, which reinforces our earlier pre-clinical data demonstrating a significant reduction in bacterial colonization on catheter devices when using UroShield™.”

NanoVibronix, Inc. (NAOV), closed Wednesday's trading session at $3.33, down 4.59%, on 3,709 volume with 33 trades. The average volume for the last 3 months is 5,052 and the stock's 52-week low/high is $3.26/$5.00.


The QualityStocks Company Corner

DPW Holdings, Inc. (NYSE American: DPW)

The QualityStocks Daily Newsletter would like to spotlight DPW Holdings, Inc. (DPW).

Diversified holding company DPW Holdings (NYSE American: DPW) this morning announced that its CEO and Chairman, Milton "Todd" Ault, III will be presenting at the 11th Annual LD Micro Main Event on December 4, 2018 at 5 PM ET. Joining Ault, DPW Holdings CAO Kenneth S. Cragun and CEO of Digital Power Lending William "Billy" Corbett will be available for one-on-one meetings throughout the day. To view the full press release, visit:

DPW Holdings, Inc. (NYSE American: DPW), is a diverse holding company pursuing a growth strategy of  acquiring undervalued assets with disruptive technologies with a global impact.

The company invests in diverse industries within the commercial, defense/aerospace, industrial, communication, medical, crypto-mining, hospitality, textile, and corporate investment/lending sectors. DPW has evolved and grown from being a leader in advanced power products. Through its subsidiaries, the company continues to be a leader and supplier of innovative technologies, advanced design and development services, and state-of-the-art power products and solutions.

Through its wholly owned Coolisys Technologies, Inc. subsidiary, DPW is committed to offering world-class technology-based solutions for critical applications and lifesaving services that are primarily driven by innovation. Coolisys targets to the defense, aerospace, naval, homeland security, medical, telecom, datacom and industrial markets. Its growth strategy centers on core markets that are characterized by “high barriers to entry” and require specialized products and services not likely to be commoditized. Through a portfolio of companies, Coolisys is engaged in developing and manufacturing advanced switching power products and power solutions that utilize a customized digital power management and resonant topology to attain:

  • The highest efficiency and highest density power converters and inverters
  • Specialized complex airborne high-frequency, radio frequency (RF), and microwave detector-log video amplifiers (DLVA)
  • Very high-frequency filters
  • Naval power conversion and distribution equipment

Coolisys offers its technology and services through three primary groups: the Power Solutions Group (PSG), the Defense and Aerospace Solutions Group (DSG), and the Advanced Service Industries (ASI) Group. Coolisys manages five divisions:

  • Digital Power Corporation, a leader in providing power electronics technology that is based in northern California.
  • Digital Power Limited dba Gresham Power Ltd, a designer and manufacturer of power distribution systems primarily for Naval use that is based in Salisbury, UK.
  • Microphase Corporation, a designer and manufacturer of microwave electronics technology that is based in Shelton, Connecticut.
  • Power-Plus Technical Distributors, a value-added distributor that is based in Sonora, California.
  • Enertec Systems, a developer and manufacturer of specialized advanced electronic systems for the defense and aerospace sectors that is based in Karmiel, Israel.

DPW’s portfolio of wholly owned subsidiaries also includes Digital Power Lending, LLC (DPL), a California private lending company operating under Financial Lender’s License ##60DBO-77905. DPL is dedicated to strategically providing capital to small and middle-size businesses for an equity interest in addition to loan fees and interest. DPL provides secured and unsecured debt financing for public and private companies. These loans will typically have a six to 12-month maturity and range from $250,000-$5 million. DPL is active in bridge loans, receivable financing, inter company loans and micro loans. DPL will work with a network of company owned ATMs (terminals) in California, which will help utilize its CA Finance Lending License and enable the company to offer micro loans of up to $500 or less.

Management has over 50 years of Wall Street experience of investing in, and building companies. DPL’s desire is to bring world-class companies lending opportunities while allowing main street investors to participate. Deal flow and organization comes from an extensive network of investment bankers, business brokers, family offices, and institutional clients enabling DPL to engage and fund the most compelling companies from Silicon Valley to Wall Street.

To date, DPL has funded over $19 million in loans. Since inception, DPL has internally funded over $15 million to DPW’s portfolio companies and wholly owned subsidiaries. As for companies outside DPW, DPL has lent over $4 million in commercial and real estate loans. DPL has funded INVO Bioscience, Medovex, Parallax, Alzamend Neuro, as well as hospitality clients, such as Guilia DTLA and Prep Kitchens.

Another subsidiary wholly owned by DPW is Super Crypto Mining, Inc., a cloud computing service that provides shared and managed computing resources optimized for various block chain mining solutions. Based in Newport Beach, California, Super Crypto Mining leverages its engineering expertise and existing locations to create cryptocurrency mining facilities throughout the world. The company owns and maintains the computing resources and sells access to their use. The established mining is on the Top 3 crypto-currencies with the goal of having 10,000 miners deployed in 2018. Super Crypto Mining endeavors to leverage its engineering expertise and existing global facilities (high-security defense business locations) to secure mining farms. Super Crypto Mining is a rapidly growing organization that recently strategically secured 25 mega watts to power the company’s mining farm. For crypto currency mining, locations with inexpensive power and secure capacity are minimal and hence costly. Having such a location allows the company to grow its mining business to more than 20,000 mining machines. Super Crypto Mining continues to purchase mining machines and explore opportunities to expand its services into other related areas including mining farm real estate investments, mining machine development, and mainstream blockchain projects.

DPW additionally has beneficiary ownership in MTIX International, Inc., the parent company of MTIX, Ltd. and I.AM, Inc.

MTIX was acquired by Avalanche International aka MTIX International, Inc., in August 2017 and offers “green technology” that uses a proprietary laser process to enhance the surface of textiles. This process reduces water usage by approximately 75 percent, reduces greenhouse gases by approximately 90 percent, and reduces chemical use by approximately 95 percent.

I.AM, acquired in May 2018, owns and operates hospitality offerings that include four Prep Kitchen brand restaurants and Giulia DTLA.

Utilizing a shareholder-centric approach to compensation, DPW has formulated the following 10-year objectives:

  • Achieve compounded annual revenue growth of 25-35%
  • Achieve compounded annual net Income growth of 5%
  • Achieve positive unrestricted free cash flow by the end of 2019

DPW is led by a seasoned team of successful business professionals and entrepreneurs. The company is headquartered in Newport Beach, California.

DPW Holdings, Inc. (DPW), closed the day's trading session at $0.2311, up 0.48%, on 1,261,533 volume with 2,321 trades. The average volume for the last 3 months is 1,220,669 and the stock's 52-week low/high is $0.22/$5.95.

Recent News

chart (CIIX)

The QualityStocks Daily Newsletter would like to spotlight (CIIX)., Inc. (OTCQB: CIIX) is a leading financial information website for Chinese-speaking investors in the U.S. and China. The company has gained its reputation through a consistent 18 years of providing premier financial information and is now seeking to also be recognized as a leader in the hemp-based CBD oil industry. The company has developed a Chinese-language app for the cannabis industry, is soon to launch a hemp-infused rice wine and is in the process of spinning off a CBD division.

Founded in 1999, (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website,, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site,, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. (CIIX), closed the day's trading session at $0.595, up 3.80%, on 52,869 volume with 47 trades. The average volume for the last 3 months is 555,978 and the stock's 52-week low/high is $0.365/$1.58.

Recent News


GreenBox POS, LLC (GRBX)

The QualityStocks Daily Newsletter would like to spotlight GreenBox POS, LLC (GRBX).

GreenBox POS, LLC (OTC PINK: GRBX) ("GreenBox," "GRBX," the "Company") is pleased to provide a corporate overview to shareholders following the release of its audited Q3-2018 financials released this morning, marking the completion of the Company's development stage.

GreenBox POS, LLC (GRBX) is a hardware and software technology company that builds customized payment solutions in different industries. The company is headquartered in San Diego, California, with offices in Seattle, Wash.; Las Vegas, Nevada; and Vancouver, British Columbia, Canada. GreenBox, which has been awarded five provisional patents for its blockchain-based technology, delivers a fully integrated, intuitive, easy-to-use, point of sale (POS) system for a variety of businesses across a multitude of different market sectors.

GreenBox develops all software in-house and with international subsidiaries, which allows the company to provide individualized electronics modifications in partnership with different vendors. Custom POS machines are available as an upgrade from existing solutions currently in use. First-time merchants can also take advantage of custom-built kiosk machines powered by blockchain technology, complete with e-wallet integration downloadable via Android or iOS apps, or via installed cash-loading kiosks.

GreenBox develops POS (point of sale) software and hardware solutions; DEL (delivery app, APIs to POS and PAY); PAY (payment app, providing financial APIs to all other components); and KIOSK (deposit, cash and E-wallet management). The following flagship products, services and custom hardware are currently available:

  • QuickCard – the QuickCard kiosk handles all cash issues, both for cashless operations and for legacy cash; performs direct and immediate deposits from cash to blockchain and confirms bank account availability within minutes. Accepts cash, debit/credit cards, or ACH directly to most banks while settling funds instantly. All records are stored securely on blockchain. No faster deposit solution is available in the regular and non-traditional banking systems (unless depositing cash directly into a cash machine connected to a bank branch).
  • POS Solutions – GreenBox software, developed in-house and with international subsidiaries, features operational compliance, financial audit prep, expense tracking, tax payments, register-specific features, and data fidelity controls (backup/restore, cloud security, privacy, etc.). GreenBox POS software is fully integrated with Del and Pay Systems and features front register mode and back-end admin mode, in addition to in-admin mode to manage employees, vendors, expenses, taxes and compliance. All records are stored on blockchain with data reliably secured and protected.
  • LOOPZ – This delivery software solution offers service dispatcher back-end technology with manual and automatic modes. The software is uniquely designed to be effectively utilized for mobile delivery service operations with full autonomous dispatch capabilities. LOOPZ provides the following features: two mobile apps (driver and consumer) running on Android and IOS; direct reporting to point of sale inventory and use of pay for instant settlements; separate escrow setup for tips and merchant sale; all data and information is securely hosted on a blockchain platform.

The management team at GreenBox includes CEO Fredi Nisan, who comes from the POS and merchant services business sector. He recently completed a successful exit in the POS and ERP business, which he founded and managed through the exit. Joining Nisan is Ben Errez, executive vice president, who comes from the investment, consulting and big software and hardware industries. His previous executive roles include positions at Microsoft (including engineering management of Microsoft Office for complex scripts); IBM (with which he had an exit); and Intel. Errez has also consulted the world’s biggest private economy, World Trade Center, on payment systems, security, reliability and privacy of software and hardware development.

GreenBox POS, LLC (GRBX), closed the day's trading session at $0.45, off by 4.26%, on 12,234 volume with 9 trades. The average volume for the last 3 months is 19,695 and the stock's 52-week low/high is $0.017/$1.95.

Recent News


The Flowr Corporation (TSX.V: FLWR)

The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation (FLWR).

The Flowr Corporation (TSX.V: FLWR), a vertically integrated Canadian cannabis company, anticipates that construction of its state-of-the-art indoor growing facilities will be completed in early 2019. Completion of the facilities, which will initially total 85,000 square feet, could give the company an advantage over its competition. To view the full article, visit:

The Flowr Corporation (TSX.V: FLWR), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.

Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.

Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.

In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.

Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.

Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
  • Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.

Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.

Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.

The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $3.45, up 1.47%, on 25,580 volume with 60 trades. The average volume for the last 3 months is 124,107 and the stock's 52-week low/high is $3.11/$8.00.

Recent News


RYU Apparel, Inc. (TSX.V: RYU) (OTC: RYPPF) (FRA: RYA)

The QualityStocks Daily Newsletter would like to spotlight RYU Apparel, Inc. (RYPPF).

RYU Apparel Inc. (TSX VENTURE: RYU.V, OTCQB: RYPPF), creators of urban athletic apparel, is pleased to share recent international media coverage of the brand's profile, in several publications - Mens Health, Esquire, Equinox, Womens Health, Today, Prevention, and Self. Featured products include the Tech Crew Tee, Locker Pack, Tough Tight, Wind Shell Jacket, Cardio Tight, and Versa Bra.

Engineered for the fitness, performance and lifestyle of the athletically-minded, RYU Apparel, Inc. (DBA RYU \ Respect Your Universe) (TSX-V: RYU) (OTC: RYPPF) (FRA: RYA) develops, markets and distributes apparel, bags and accessories for active people living their lives with integrity. Headquartered in Vancouver, Canada, with with four stores located in Greater Vancouver Area, British Columbia and one in Toronto, RYU opened its first U.S.-based store at the iconic Abbot Kinney Boulevard in Venice California, on August 2, 2018. Additional retail locations are slated to open soon in Etokicoke, Ontario, Canada; Brooklyn, New York; and Newport Beach, California, with plans to establish nearly two dozen more store locations by the end of 2022.

Respect Your Universe’s award-winning brand celebrates, encourages and respects an individual’s choices and journey in life, promoting a fitness lifestyle culture. Innovatively designed without compromise and tailored for fit, comfort and durability, RYU exists to facilitate human performance. RYU’s urban athletic apparel and accessories product line has been featured by some of the most influential fitness and outdoor lifestyle publications and social media connectors.

The company recently was honored in Madrid, Spain, as a 2018 Finalist in the World Retail Awards in the categories of “Retail Start Up of the Year” and “Social Media Campaign of the Year,” (#RYUOneMoreRep). RYU is one of only two Canadian companies that qualified as finalists among many global retailers across all categories of the World Retail Awards annual event. The World Retail Awards have been recognizing the very best retailers and retail initiatives across a range of categories since 2007.

Marcello Leone, CEO of RYU, said the company’s inclusion in the prestigious lineup of finalists was gratifying, stating, “Being chosen by the World Retail Awards is a fantastic accolade. We are proud to be among a group of global peers that are considered to become the next generation of iconic brands. #RYUOneMoreRep Media Campaign is also another confirmation of the social aspect that permeates our brand and the impact we are having in our community.”

In addition to its retail locations, RYU generates sales through its e-commerce platform and has developed strategic relationships with companies such as Global-E, Netamorphosis, Fancy and the NHL Vancouver Canucks to expand its reach. RYU is also building connections with influential leaders and social media influencers who represent the company’s values of aliveness, bold expression, curiosity, discipline and respect. Under RYU’s Connector Program, each leader actively engages in community charities, volunteer efforts and participates in charity programs. Among the famous personalities and community leaders connecting with the RYU brand are:

  • Alexandra Ianculescu, a Canadian National Team Olympic Speed Skater
  • Ben Carr, professional trainer
  • Tori Katongo, personal trainer, singer, actor, dancer
  • Simon “Thor” Damborg, head coach at Raincity Athletics
  • Cassie Hawrysh, a Canadian National Team Skeleton Racer
  • Dai Manuel, lifestyle mentor and author of “The WholeLife Manifesto”

Company CEO Leon is the founder of Naturo Group Investment Inc., a company that sells nutritional beverages, and also is the former VP of operations and president of LEONE, an independent high fashion specialty store in Vancouver, Canada. Chief Financial Officer Pedro Villa is a certified CPA who has held several senior positions in various North American companies. Brett Pawson, senior VP of retail and operations, has more than 15 years of experience in sales and operations in the wellness, consumer goods and retail sectors.

RYU’s strategic focus is on becoming a global leader as a fitness and training apparel and accessories brand for athletes in multiple disciplines. RYU’s goal is to facilitate human performance by honoring and celebrating the extraordinary oneness of humanity by respecting each other’s differences – Respect Your Universe.

RYU Apparel, Inc. (RYPPF), closed the day's trading session at $0.1038, off by 5.64%, on 24,300 volume with 8 trades. The average volume for the last 3 months is 122,083 and the stock's 52-week low/high is $0.05/$0.255.

Recent News


SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint, Inc. (SING) was featured today in a report by CannabisNewsWire which examines how the Federal Business Opportunities website recently featured an advert of great interest to the cannabis industry. In that advert, the federal government was inviting entities to submit their capability statements if they felt they could grow or supply different quantities of marijuana strains or products.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.021, up 9.95%, on 5,517,104 volume with 178 trades. The average volume for the last 3 months is 4,677,146 and the stock's 52-week low/high is $0.0185/$0.133.

Recent News


Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Specialty product supplier Sugarmade, Inc. (OTCQB: SGMD) is sweetening its investment in the increasingly legalized hemp sales markets by strengthening its grasp on hydroponic system supplies and inverting capital into cultivation.

Sugarmade, Inc. (SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include:;; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.


CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.10, off by 0.99%, on 983,553 volume with 85 trades. The average volume for the last 3 months is 2,607,090 and the stock's 52-week low/high is $0.05/$0.43.

Recent News


Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Supreme Cannabis Co. (TSX-V: FIRE) (OTCQX: SPRWF). Also today, NetworkNewsWire released a report on the company detailing how, ever since 7ACRES was federally licensed to produce on March 11, 2016, Supreme Cannabis has been pursuing its mission of becoming the foremost international cultivator of cannabis. The company is proficient at cultivating high-quality cannabis at scale. Since 2014, Supreme has been at the center of the cannabis space in pursuit of the significant opportunity in cannabis, rooted in Canada, with global opportunities on the horizon as well.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed the day's trading session at $1.20159, up 5.40%, on 202,101 volume with 265 trades. The average volume for the last 3 months is 942,212 and the stock's 52-week low/high is $0.95/$2.79.

Recent News


Victory Marine Holdings Corp. (VMHG)

The QualityStocks Daily Newsletter would like to spotlight Victory Marine Holdings Corp. (VMHG).

Miami-based Victory Marine Holdings (OTC: VMHG) operates within Florida, the state with the largest recreational marine market in the U.S. To view the full article, visit:

Victory Marine Holdings Corp. (VMHG) is a world-class yacht sales, brokerage and consulting firm with a sprawling inventory of new and used boats, financing, insurance, documentation and recreational marine accessories. Located in Miami, Florida – the “yacht capital of the world” – Victory Marine has over 20 years of experience in an industry hailed as “an American pastime and economic engine” by the National Marine Manufacturers Association (“NMMA”).

According to the NMMA, marine sales reached $39 billion in 2017. To capture its share of this market, Victory Marine has established partnerships with several selective manufacturers and is pursuing opportunities for vertical growth. While the company’s near-term focus is on expansion of its inventory and sales team, its longer-term plans reflect the current state of the broader yacht industry.

Marine sales are at a 10-year high, and though yacht manufacturers are operating at full capacity, delivery of some products can take longer than 18 months. As a result, Victory Marine is taking steps to establish its own pipeline. Management is currently in negotiations with several yacht manufacturers to build the company its own unique, private-label design, which would enable Victory Marine to quickly deliver a superior product to its clients.

Demand for recreational boat trailers is also on the rise, with growth reported for nearly all powerboat segments. Florida continues to ride the top of that crest with sales of powerboats, trailers, and accessories up 10 percent in 2017 to $2.9 billion, followed by Texas ($1.7 billion) and Michigan ($982 million).

Victory Marine’s wholly owned Excalibur Trailers USA subsidiary is set to take advantage of this market, and is approved by the Society of Automotive Engineers (SAE International) to build custom marine aluminum trailers for recreational boats, as well as for commercial boat transport. Excalibur Trailers USA has filed the necessary paperwork to trademark its brand name and logo and is seeking a suitable manufacturing facility in South Florida for production of powerboat, sailboat, catamaran, powerboat and Jet Ski trailers.

Leading Victory Marine to capture its share of the market is company CEO Orlando Hernandez, whose experience in the marine industry includes negotiation, business planning, investor relations, operations management and sales. He is joined by veteran yacht broker Gary Beaver, who has more than 20 years of successful yacht sales and industry experience. Beaver brings to Victory Marine his portfolio of approximately 25 vessel listings, valued in excess of $10 million.

Victory Marine Holdings Corp. (VMHG), closed the day's trading session at $0.05519, off by 29.24%, on 177,317 volume with 16 trades. The average volume for the last 3 months is 59,540 and the stock's 52-week low/high is $0.0575/$0.97.

Recent News


Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

Youngevity International, Inc. (NASDAQ: YGYI) was highlighted today in a report by Fundamental Markets. To read the full Youngevity International Inc. (YGYI) report, download it here:

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $7.01, up 1.89%, on 106,580 volume with 465 trades. The average volume for the last 3 months is 538,646 and the stock's 52-week low/high is $3.167/$16.25.

Recent News


Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4)

The QualityStocks Daily Newsletter would like to spotlight Redfund Capital Corp. (PNNRF).

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) was featured today in a report by CannabisNewsWire which examines how the Federal Business Opportunities website recently featured an advert of great interest to the cannabis industry. In that advert, the federal government was inviting entities to submit their capability statements if they felt they could grow or supply different quantities of marijuana strains or products.

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4) is a merchant bank focused on providing debt and equity funding in the mid to late stages of a target company’s development and for technologies that are developed and validated by revenues. Redfund’s current focus is on medical cannabis, hemp and cannabidiol (CBD) related and healthcare-related companies.

As the first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility, Redfund is effectively bridging finance gaps and helping revenue-producing medical cannabis-related companies grow and build their valuations without prematurely diluting their equity.

The central components of the company’s business strategy are:

  • Establishing the foundation of a loan portfolio that generates revenues through monthly interest income from loans to cover all general and administrative expenses related to day-to-day operations.
  • Growing shareholder value by converting all or part of loans and warrants into equity in portfolio clients as clients build their valuations by entering the public markets or becoming the high-priced targets of larger entities.

Redfund was designed by bankers and entrepreneurs possessing years of experience in business, consulting, capital markets, corporate finance and healthcare services. The company is actively looking beyond borders and creating global companies that have strong fundamentals and are ready to expand.

Redfund’s investments are deployed to companies that have demonstrated success in their business but need a capital bridge in order to expand. Redfund’s team of professionals vet every project and analyzes each prospective client’s financials and business plans. Once a project is approved, Redfund’s legal team carefully scrutinizes the collateral used to securitize the individual loans.

The strategy employed by Redfund includes:

  • Diversifying investments in Canada and other countries
  • Building an international footprint with established national leaders
  • Funding new drug delivery systems and helping nutraceuticals become mainstream drugs
  • Introducing companies to Canada as a viable option for public listings
  • Becoming a premier go-to lender for established companies

The company’s revenue sources include:

  • Interest-bearing debt instruments with asset-backed collateral to securitize loans
  • Equity kicker of warrants coverage on original loan
  • Conversion ability of loan in its entirety
  • Advisory fees from contracts for consulting on growth strategies
  • Right of first refusal on future financing in each company funded

Redfund Capital Corp. (PNNRF), closed the day's trading session at $0.3836, even for the day. The average volume for the last 3 months is 933 and the stock's 52-week low/high is $0.244/$0.505.

Recent News


Pacific Software, Inc. (PFSF)

The QualityStocks Daily Newsletter would like to spotlight Pacific Software, Inc. (PFSF).

Given its capability to provide a highly effective trust mechanism that can track complex transactions using cryptographically secure Hyperledger Blockchain technology, the proprietary e-commerce trade platform under development by Pacific Software, Inc. (OTC: PFSF) could also play a role in boosting trade between the Asian and Latin American giants.

Pacific Software, Inc. (PFSF) is focused on the design, development, and distribution of Hyperledger blockchain technology solutions for application to the specific needs of agriculture and the opioid epidemic.

The basic requirements of the systems to be developed include high-throughput transaction processing, traceability or tracking, visibility or monitoring, and transparency throughout the supply and value chains for the stakeholders. The development of this architecture will serve as an online commercial portal to service Pacific Software’s B2B accounts in the sectors below.

For application of its Agri-blockchain based system, Pacific Software will target farm-to-consumer exports to increase transparency, combat theft and counterfeit products, and reduce the health risks associated with shipping “tainted” agricultural products to other countries.

Controlled Substances
With the misuse of opioids on the rise worldwide, Pacific Software aims to apply its blockchain-based system to track opioids from pharmaceutical production to consumers and attempt to identify “Bad Actors” in the supply chain and fight against the global epidemic.

Business Model
The portal will be structured in a B2B format where clients will pay the company transaction fees, royalties, cash, cash equivalents and other forms of compensation to utilize its Hyperledger blockchain applications for their business models.

As the company executes these strategies, each Hyperledger blockchain-based system designed may be organized separately in wholly owned subsidiaries. To enhance its portfolio of holdings, Pacific Software may consider investments in companies where selected markets have imminent profitable results, providing appreciable value for investors and shareholders.

Pacific Software, Inc. (PFSF), closed the day's trading session at $5.50, even for the day. The average volume for the last 3 months is 61 and the stock's 52-week low/high is $3.50/$5.50.

Recent News


FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF)

The QualityStocks Daily Newsletter would like to spotlight FinCanna Capital Corp. (FNNZF).

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) a royalty company for the U.S. licensed medical cannabis industry is pleased to announce that it will be a panel presenter at The Private Capital Markets Association of Canada (“PCMA”) to be held at The Glencoe Club, Calgary AB, Thursday November 22.

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages extensive investment expertise and industry experience to benefit its shareholders and portfolio companies.

Medical Cannabis Market

According to Ameri Research, the global market for licensed medical cannabis is growing at a compound annual growth rate (CAGR) of more than 21%, on track to exceed $63.5 billion by 2024. Within this market, FinCanna has identified considerable opportunity in California, the fifth largest economy in the world and the largest medical cannabis market in North America. Arcview Group forecasts California’s legal cannabis industry will grow at 21.1% CAGR to $6.5 billion in 2020, generating more than $1 billion in tax revenue.

Royalty Model & Portfolio

FinCanna’s “whole capital” solution for businesses in the licensed medical cannabis sector includes the provision of capital investment for a percentage of their future revenues. The FinCanna Capital Solution utilizes a royalty arrangement to deliver capital, in order to facilitate the growth or other specific objectives of its investees, and ensure the business opportunity is optimized. This model provides an alternative or complement to debt and equity financing, allowing investees to maintain financial flexibility and control of their business rather than entering into arrangements that may include restrictive debt structures or giving up an ownership stake.

FinCanna’s portfolio includes Cultivation Technologies, Inc. (“CTI”), a team of experts from Fortune 150 agriculture, medical cannabis, law, engineering and technology companies. FinCanna is providing funding to CTI for its planned, fully entitled, large-scale indoor medical cannabis facility to be developed in Coachella, California.

CTI has established an interim medical cannabis extraction facility (the “Interim Facility”) that will produce licensed medical cannabis products until the Coachella Project is complete. CTI is currently expanding its product line, Coachella Premium, to include vaporizer cartridges. Initial market feedback gathered during the product development phase indicates that Coachella Premium’s vaporizer cartridges offer a unique proposition within the vaporizer market, one of the fastest growing verticals in the cannabis market.

The Interim Facility can process up to 6,000 pounds of biomass per month, the equivalent of approximately 3.7 million grams of raw oil per year, with room for expansion. It is expected that the completed Coachella Project will be able to process 30,000 to 50,000 pounds of biomass per month, or the equivalent of 18 million grams to 30 million grams of raw oil per year.

Additionally FinCanna has entered into a royalty agreement with Green Compliance, a provider of point-of-sale software solution (“ezGreen”) for licensed medical cannabis dispensaries and cultivators. Green Compliance helps its customers comply with both the Health Insurance Portability and Accountability Act (“HIPAA”) and State Laws by ensuring patients’ confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations.

FinCanna has also signed binding term sheet with Oakland, California-based Gram Co Holdings, subject to due diligence by FinCanna. Gram Co is a cannabinoid research and refinement facility focused providing B2B and B2C products and services to licensed medical dispensaries, infused product manufacturers, and numerous others in the cannabis supply chain. The company is also retrofitting a large, state-of-the-art medical cannabis extraction laboratory, which is expected to be operating in 2018.

The foregoing contains forward-looking statements regarding Cultivation Technologies Inc. (“CTI”) which are subject to risks, uncertainties and contingencies which include, but are not limited to the statements relating the future construction and completion of the CTI medical cannabis facility in Coachella, California, and the projected biomass processing and raw oil production at the facility. Such forward looking statements are based on assumptions regarding the construction, completion and operations of CTI’s proposed facility, including that CTI will obtain the financing required to build and equip its proposed facility, that CTI will obtain the additional financing required operate the facility, that construction facility is completed on time and budget, that CTI obtains state licenses to operate on a permanent basis, and that the equipment used in the cultivation of medical cannabis performs at scale in a similar way it performs at CTI’s pilot tests.

FinCanna Capital Corp. (FNNZF), closed the day's trading session at $0.1339, up 0.30%, on 4,300 volume with 6 trades. The average volume for the last 3 months is 55,972 and the stock's 52-week low/high is $0.10/$0.8736.

Recent News


Sunniva, Inc. (CSE: SNN) (OTC: SNNVF)

The QualityStocks Daily Newsletter would like to spotlight Sunniva, Inc. (SNNVF).

Sunniva Inc. (CSE:SNN) (OTCQB:SNNVF), a North American provider of cannabis products and services, plans to release its results for the third quarter 2018, after market close on Wednesday, November 28, 2018.

Sunniva, Inc. (CSE: SNN) (OTC: SNNVF) is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – committed to delivering safe, consistent, high-quality products and services. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc., CP Logistics, LLC, Natural Health Service Ltd., and Full-Scale Distributors, LLC. Sunniva’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built cGMP-compliant greenhouses, offering best quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education, and sourcing better therapeutic delivery devices.

The company is establishing sophisticated distribution channels, including Sunniva’s ownership of Natural Health Services cannabis clinics in Canada with over 95,000 active patients, to purchase the significant quantities of high quality Sunniva-branded and Sunniva private-labeled cannabis products.

Sunniva is an ancient English name which means, “Gift of the Sun.” Sunniva’s team of horticulturists, scientists and engineers is helping to set best practices for the industry, believing that sun-grown, solar-powered cultivation is the most sustainable and cost-effective way to grow high-quality, premium cannabis.

The Sunniva Family includes:

CP Logistics, LLC

Through its subsidiary, CP Logistics LLC, Sunniva is developing Sunniva Campus, a state-of-the-art, purpose-built greenhouse facility in Cathedral City, California. This modern purpose-built, agri-technology greenhouse will adhere to the Current Good Manufacturing Practice (cGMP) regulations that assure proper design, monitoring and control of manufacturing processes and facilities.

Phase 1 of the project includes a fully funded 325,000 square foot greenhouse capable of producing 60,000 kg per year of dry cannabis at capacity with operations commencing Q3 2018. Approximately 30 percent of initial total production will be converted into oils and extracts. Phase 2 is expected to increase the greenhouse by 165,000 square feet and grow production by about 40,000 kg per year.

These uniquely sealed greenhouses are designed to deploy custom, automation assembly line cultivation processes at a large scale. Energy consumption will be reduced while utilizing the energy of the sun and microclimatic controls to provide precise growing conditions. The greenhouse will recirculate air for more efficient climate control, and the company’s Integrated Pest Management System is designed to ensure every plant grown is certified clean and free of all contaminants and pesticides.

Sunniva Medical Inc.

Sunniva Medical Inc. is designing and preparing to break ground on the Sunniva Canada Campus encompassing 700,000 square feet of purpose-built cGMP greenhouse facilities in the Okanagan Valley, British Columbia. The total campus is expected to produce 100,000 kg of premium medical cannabis a year plus additional trim used for extraction. This facility will produce pesticide-free products and will convert trim to extracted products such as cannabis oil that can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams.

Sunniva and Canopy Growth Corporation (“Canopy Growth”) recently announced a large take or pay supply agreement. Under the terms of the agreement, Canopy Growth will purchase up to 45,000 kilograms of dried cannabis annually commencing Q1 2019, which includes the distribution of Sunniva branded products. Sunniva Medical is a late-stage applicant under Canada’s ACMPR and is in the final review stage of the process.

Natural Health Services Ltd.

Natural Health Services (“NHS”) owns and operates a network of eight medical clinics in Canada specializing in medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). NHS connects licensed producers to their 21 physicians and patients with its proprietary SPARK software which utilizes a software-as-a-service revenue model. To date, there are 27 integrated licensed producers utilizing the SPARK software.

In-house physicians specializing in the endocannabinoid system provide expert consultation, education and recommendations for targeted phytoceutical remedies and wellness plans to improve the quality of life for all patients. NHS enjoys a long-term relationship with patients due to the quality of its physician-patient experience. A rapidly expanding NHS cannabis clinic network serves 94,000 active patients in Canada. NHS has also initiated a pilot program with a national pharmacy chain to aggregate more patients.

Full-Scale Distributors, LLC

Full-Scale Distributors, LLC is an industry leading provider of custom, private-label vaporizers through its brand, Vapor Connoisseur. The company currently serves the needs of over 80 top brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative therapeutic delivery devices. Products are tailored to client needs, ensuring both safety and reliability.

Sunniva’s highly experienced management team is building partnerships with leading scientists, universities and clinical trial groups to deliver proprietary cannabis formulations to a broad spectrum of health ailments and conditions. These global partners require cGMP-certified facilities for the processing and manufacturing of cannabis products. Sunniva is committed to providing safe, pesticide-free, high quality, reproducible cannabis medicines.

Leading Sunniva is co-founder, chairman and CEO Dr. Anthony (Tony) Holler. He is the former CEO and founder of ID Biomedical, which was acquired in 2005 for $1.7 billion by GlaxoSmithKline. He is also the former chairman of Corriente Resources Inc., which was sold for approximately $700 million to CRCC-Tongguan Investment Co. Holler is currently chairman of CRH Medical Corporation, a public company trading on the TSX and NYSE. His expertise includes strategic planning, mergers and acquisitions and financing with a singular focus on increasing shareholder value.

Holler is joined by co-founder Leith Pedersen, who serves as president of Sunniva. Pedersen is the former owner and CEO of Vida Wealth Management Bahamas and was a former investment advisor at Canaccord Wealth Management. He is a former partner and director at JF Mackie and Company, an independent brokerage firm in Calgary, Alberta, that managed capital in excess of $2 billion for high net worth clients. Pedersen’s expertise is in corporate strategy, financing and mergers and acquisitions.

Sunniva, Inc. (SNNVF), closed the day's trading session at $3.256, up 1.75%, on 95,233 volume with 165 trades. The average volume for the last 3 months is 98,895 and the stock's 52-week low/high is $3.1047/$16.00.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.